Exploring Maternal Mental Health and Neonatal Risks in SSRI Study – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
” In a large national cohort from Finland (over 1.2 million births), SSRI exposure was linked to:
- Lower risks of very preterm birth and low birth weight
- Higher risk of neonatal adaptation symptoms (eg, breathing problems, low 5-minute Apgar, neonatal care)
- Persistent increased risk of gestational diabetes
Takeaway: SSRI use during pregnancy has complex, independent effects — balancing maternal mental health benefits with neonatal adaptation considerations.
Read the full text to learn more.”
Proceed to the video attached to the post.
Title: SSRI use during pregnancy and maternal depression – a nationwide birth cohort study on risks to the mother and the newborn
Authors: Heli Malm, Alan S. Brown, Keely Cheslack-Postava, Mika Gissler, David Gyllenberg, Emmi Heinonen, Susanna Hinkka-Yli-Salomäki, Ian W. McKeague, Aleksi Tornio, Subina Upadhyaya, Andre Sourander
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 31, 2026, 17:24Riikka Leppänen: Happy to Attend the Nordic Fertility Society Congress 2026
-
Aug 31, 2026, 17:18Brian A. Levine: The Question of Whether to Try Again is One of The Hardest in Medicine
-
Aug 31, 2026, 17:13Aumatma Simmons: Trying to Conceive Can Feel Like a Full-Time Job…
-
Aug 31, 2026, 17:11Nalanda Jayadev: What if “Knowing Early” Could “Change” a Child’s Future?
-
Aug 31, 2026, 17:04Oluyemisi Famuyiwa: Your Fertility Story Should Begin with Knowledge, Not a Crisis
-
Aug 31, 2026, 17:01Vasileios Sarafis: The S.A.F.A.R.I. Protocol – 6 Domains, 1 Structured Plan
-
Aug 31, 2026, 16:54Amitha Nanjundaiah: Should We Aim for Better Oocyte Quality or Greater Oocyte Numbers?
-
Aug 31, 2026, 16:51Sahana C: In Fertility, the Messiness of Clinical Analytics Is Real
-
Aug 31, 2026, 16:46Elham Mohammadzadeh: Attending Excellent Scientific Sessions at NFS 2026